Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28746197 | 1.00 | TP53 (0.30) | TP53TSHR | |
| Benzene SCHEMBL28239758 | 1.00 | TP53 (0.30) | TP53TSHR | |
| Benzene SCHEMBL28256869 | 1.00 | TP53 (0.30) | TP53TSHR | |
| Thiophene SCHEMBL4349054 | 0.95 | — | — | |
| Benzene SCHEMBL15255212 | 0.95 | TP53 (0.33) | TP53TSHR | |
| SCHEMBL27690384 | 0.95 | TP53 (0.33) | TP53TSHR | |
| Thiophene SCHEMBL1222753 | 0.95 | — | — | |
| Benzene SCHEMBL1975626 | 0.95 | TP53 (0.33) | TP53TSHR | |
| SCHEMBL40554 | 0.95 | — | — | |
| Benzene SCHEMBL28210283 | 0.95 | TP53 (0.33) | TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023182958-A1 | N'-(BENZO[D]THIAZOLE-2-YL)-4-BROMOBENZOHYDRAZIDE SALTS FOR TREATMENT OF MULTIPLE MYELOMA AND A METHOD FOR SYNTHESIS THEREOF | T.C. ANKARA UNIVERSITESI REKTORLUGU (TR) | 2023-09-28 | — | — | WO | claimed |
| CN-107135947-B | Willow rataria seedling method for tissue culture | 江苏沿江地区农业科学研究所 | 2019-11-19 | — | — | CN | claimed |
| EP-0096319-B1 | METHOD FOR PREVENTING SCALE DEPOSITION IN THE POLYMERIZATION OF ETHYLENICALLY UNSATURATED MONOMERS | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-03-26 | — | — | EP | claimed |
| EP-0096319-A1 | Method for preventing scale deposition in the polymerization of ethylenically unsaturated monomers | Shin-Etsu Chemical Co., Ltd. (JP) | 1983-12-21 | — | — | EP | claimed |
| JP-3062458-A | — | — | None | — | — | JP | disclosed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2025-06-10 | — | — | US | disclosed |
| US-20250000871-A1 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-01-02 | — | — | US | disclosed |
| US-12064439-B2 | Phenothiazine diaminium salts and their use | WISTA LABORATORIES LTD. (SG) | 2024-08-20 | — | — | US | disclosed |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2024-07-25 | — | — | US | disclosed |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2024-04-09 | — | — | US | disclosed |
| WO-2023182958-A1 | N'-(BENZO[D]THIAZOLE-2-YL)-4-BROMOBENZOHYDRAZIDE SALTS FOR TREATMENT OF MULTIPLE MYELOMA AND A METHOD FOR SYNTHESIS THEREOF | T.C. ANKARA UNIVERSITESI REKTORLUGU (TR) | 2023-09-28 | — | — | WO | disclosed |
| WO-1998052017-A1 | APPARATUS AND METHODS FOR DETERMINING THE TIME OF DEATH OF AN ORGANISM | BIOMAX TECHNOLOGIES, INC. (CA) | 1998-11-19 | — | — | WO | disclosed |
| US-5744511-A | BLEND OF COUMARIN DYES, ACID GENERATOR AND ARYL BORATE | TOKUYAMA CORPORATION (JP) | 1998-04-28 | — | — | US | disclosed |
| EP-0738928-A2 | Visible-ray polymerization initiator and visible-ray polymerizable composition | TOKUYAMA CORPORATION (JP) | 1996-10-23 | — | — | EP | disclosed |
| US-5500760-A | Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same | DONNELLY CORPORATION (US) | 1996-03-19 | — | — | US | disclosed |
| EP-0531143-A2 | Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same | DONNELLY CORPORATION (US) | 1993-03-10 | — | — | EP | disclosed |
| JP-H0362458-A | LITHIUM BATTERY | MITSUBISHI ELECTRIC CORP | 1991-03-18 | — | — | JP | disclosed |
| EP-0096319-B1 | METHOD FOR PREVENTING SCALE DEPOSITION IN THE POLYMERIZATION OF ETHYLENICALLY UNSATURATED MONOMERS | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-03-26 | — | — | EP | disclosed |
| EP-0096319-A1 | Method for preventing scale deposition in the polymerization of ethylenically unsaturated monomers | Shin-Etsu Chemical Co., Ltd. (JP) | 1983-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | TP53 1630/4885TSHR 1453/4885 |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | TP53 1921/4885TSHR 1169/4885 |
| US-12064439-B2 | Phenothiazine diaminium salts and their use | QDPR, SLC35A1, SLC6A7 | TP53 1873/4885TSHR 1575/4885 |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | TP53 1630/4885TSHR 1453/4885 |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | TP53 1921/4885TSHR 1169/4885 |
| US-20250000871-A1 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | QDPR, SLC35A1, SLC6A7 | TP53 1873/4885TSHR 1575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.